The global medical oxygen gas cylinders market was valued at $2,971.40 million in 2020, and is estimated to reach $5,337.50 million by 2030, growing at a CAGR of 5.70% from 2021 to 2030.
Medical oxygen gas cylinders are regularly needed by medical care staff for therapy and diagnostic purposes. These gas systems, for instance, oxygen concentrators and compressed oxygen gas cylinders, are significantly utilized in homecare settings and are generally preferred by old patients who experience issues in mobility and rely upon a reliable oxygen supply.
Some basic chronic medical conditions such as chronic obstructive pulmonary diseases (COPD), emphysema, and chronic bronchitis, a typical long-term impact of smoking, require oxygen treatment or supplemental oxygen to get enough oxygen. Furthermore, different kinds of oxygen systems are utilized to convey controlled measure of oxygen to patients. In addition, medical oxygen gas has high purity oxygen that is utilized for clinical treatments and is produced for use in human body.
Long-term exposure to particulate air pollution is linked with increased mortality and morbidity. According to the CDC, tobacco smoke was found to be the key factor in progression and development of respiratory disorders in the U.S. Moreover, exposure to air pollutants near workplaces and homes, respiratory infections, and genetic factors also play a key role in the market growth.
In developing regions, outdoor air quality plays a greater role in progression and development of COPD (chronic obstructive pulmonary disease) than in developed regions. In addition, according to data published by the Global Asthma Report, in 2018, around 339 million people were affected by asthma. Further, according to the CDC, in 2020, around 26 million Americans have asthma. During the next 20 years, the number of Americans with asthma is expected to grow by 10%. Hence, such factors are expected to boost the market growth.
Increase in population of smokers is expected to drive growth of the medical oxygen gas cylinders market. Cigarette smoking is the primary cause of developing COPD and asthma. For instance, according to the CDC, in 2018, around 480,000 deaths occur each year in the U.S due to smoking. In addition, as per data published by the WHO in 2019, the estimated one billion smokers in the world, 80% live in low- and middle-income countries. This factor is thus anticipated to boost demand for oxygen cylinders and further drives the market growth.
Furthermore, rise in prevalence of COVID-19 cases across the globe and growth in number of cases of chronic diseases also supplement the market growth. Optimal medical infrastructure utilization has become a high priority for governments worldwide during the COVID-19 pandemic. Furthermore, special attention is drawn to both importers and local manufacturers of medical oxygen gas systems to ensure its uninterrupted supply to designated COVID-hospital identified by local administration. For instance, as per the Worldometer, as of April 27th, 2021, there were 19,172,322 active cases of COVID-19 across the globe.
Thus, oxygen gas cylinders are required for increasing demand from medical clinics and home care settings. Medical oxygen gas cylinders are available in various sizes depending on requirement. In hospital, oxygen gas treatment is executed on patients for therapy of chronic health issues to improve energy levels, for rest, and superior quality life of patients. Oxygen is generally utilized in medical clinics for therapy of various intense and chronic diseases. These clinical oxygen chambers are generally utilized in ambulances to manage emergency circumstances. Medical oxygen gas cylinders have huge need for patients facing different infections such as asthma and chronic diseases.
However, high cost of oxygen gas cylinders hamper the market growth. In addition, Moreover, entry of numerous local manufacturers has affected product quality with the use of substandard materials. Inadequate quality checks for medical oxygen gas cylinders are responsible for use of such substandard quality of manufactured products. Proper inspection of these medical oxygen gas cylinders is required during their manufacturing and maintenance throughout their lifespan. Many medical oxygen gas cylinders have manufacturing defects that can result in various infections. Thus, such factors impede the market growth. Moreover, rise in investments in healthcare and increase in technological development in medical oxygen gas cylinders offer ample opportunities for further growth of the market.
The global medical oxygen gas cylinders market is segmented on the basis of technology, product, end user, and region. By technology, the market is categorized into pulse flow and continuous flow. By technology, it is bifurcated into portable and fixed. By end user, it is divided into hospital and home healthcare. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global medical oxygen gas cylinders market include Koninklijke Philips N.V., Invacare Corporation, Nidek Medical Products, Inc., Inogen, Inc., Messe Düsseldorf GmbH, ResMed, DeVilbiss Healthcare LLC, Airgas Inc, Messer Group GmbH, and OrientMEd International.
Medical oxygen gas cylinders are regularly needed by medical care staff for therapy and diagnostic purposes. These gas systems, for instance, oxygen concentrators and compressed oxygen gas cylinders, are significantly utilized in homecare settings and are generally preferred by old patients who experience issues in mobility and rely upon a reliable oxygen supply.
Some basic chronic medical conditions such as chronic obstructive pulmonary diseases (COPD), emphysema, and chronic bronchitis, a typical long-term impact of smoking, require oxygen treatment or supplemental oxygen to get enough oxygen. Furthermore, different kinds of oxygen systems are utilized to convey controlled measure of oxygen to patients. In addition, medical oxygen gas has high purity oxygen that is utilized for clinical treatments and is produced for use in human body.
Long-term exposure to particulate air pollution is linked with increased mortality and morbidity. According to the CDC, tobacco smoke was found to be the key factor in progression and development of respiratory disorders in the U.S. Moreover, exposure to air pollutants near workplaces and homes, respiratory infections, and genetic factors also play a key role in the market growth.
In developing regions, outdoor air quality plays a greater role in progression and development of COPD (chronic obstructive pulmonary disease) than in developed regions. In addition, according to data published by the Global Asthma Report, in 2018, around 339 million people were affected by asthma. Further, according to the CDC, in 2020, around 26 million Americans have asthma. During the next 20 years, the number of Americans with asthma is expected to grow by 10%. Hence, such factors are expected to boost the market growth.
Increase in population of smokers is expected to drive growth of the medical oxygen gas cylinders market. Cigarette smoking is the primary cause of developing COPD and asthma. For instance, according to the CDC, in 2018, around 480,000 deaths occur each year in the U.S due to smoking. In addition, as per data published by the WHO in 2019, the estimated one billion smokers in the world, 80% live in low- and middle-income countries. This factor is thus anticipated to boost demand for oxygen cylinders and further drives the market growth.
Furthermore, rise in prevalence of COVID-19 cases across the globe and growth in number of cases of chronic diseases also supplement the market growth. Optimal medical infrastructure utilization has become a high priority for governments worldwide during the COVID-19 pandemic. Furthermore, special attention is drawn to both importers and local manufacturers of medical oxygen gas systems to ensure its uninterrupted supply to designated COVID-hospital identified by local administration. For instance, as per the Worldometer, as of April 27th, 2021, there were 19,172,322 active cases of COVID-19 across the globe.
Thus, oxygen gas cylinders are required for increasing demand from medical clinics and home care settings. Medical oxygen gas cylinders are available in various sizes depending on requirement. In hospital, oxygen gas treatment is executed on patients for therapy of chronic health issues to improve energy levels, for rest, and superior quality life of patients. Oxygen is generally utilized in medical clinics for therapy of various intense and chronic diseases. These clinical oxygen chambers are generally utilized in ambulances to manage emergency circumstances. Medical oxygen gas cylinders have huge need for patients facing different infections such as asthma and chronic diseases.
However, high cost of oxygen gas cylinders hamper the market growth. In addition, Moreover, entry of numerous local manufacturers has affected product quality with the use of substandard materials. Inadequate quality checks for medical oxygen gas cylinders are responsible for use of such substandard quality of manufactured products. Proper inspection of these medical oxygen gas cylinders is required during their manufacturing and maintenance throughout their lifespan. Many medical oxygen gas cylinders have manufacturing defects that can result in various infections. Thus, such factors impede the market growth. Moreover, rise in investments in healthcare and increase in technological development in medical oxygen gas cylinders offer ample opportunities for further growth of the market.
The global medical oxygen gas cylinders market is segmented on the basis of technology, product, end user, and region. By technology, the market is categorized into pulse flow and continuous flow. By technology, it is bifurcated into portable and fixed. By end user, it is divided into hospital and home healthcare. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global medical oxygen gas cylinders market include Koninklijke Philips N.V., Invacare Corporation, Nidek Medical Products, Inc., Inogen, Inc., Messe Düsseldorf GmbH, ResMed, DeVilbiss Healthcare LLC, Airgas Inc, Messer Group GmbH, and OrientMEd International.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global mental health market to identify the prevailing opportunities.
- This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region- & country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Product
- Pulse Flow
- Continuous Flow
By Technology
- Portable
- Fixed
By End User
- Hospital
- Home Healthcare
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Koninklijke Philips N.V.
- Invacare Corporation
- Nidek Medical Products, Inc.
- Inogen, Inc.
- Messe Düsseldorf GmbH
- ResMed
- DeVilbiss Healthcare LLC
- Airgas Inc
- Messer Group GmbH
- OrientMEd International
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.1.1. Secondary research
1.1.2. Primary research
1.1.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Top player positioning
3.4. Market dynamics
3.4.1. Drivers, restraints, and opportunity
3.4.2. Drivers
3.4.2.1. Daily exposure to environmental pollution
3.4.2.2. Increase in population susceptible to indoor air pollutants
3.4.2.3. Increase in population of active smokers
3.4.3. Restraints
3.4.3.1. Stringent regulatory procedures
3.4.3.2. High costs of the oxygen cylinders
3.4.4. Opportunities
3.4.4.1. High growth potential in emerging markets
3.4.4.2. Increase in geriatric population
3.5. Impact of COVID-19 on Medical oxygen gas cylinders market
3.5.1. Overview
3.5.2. Impact analysis
CHAPTER 4: MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Pulse Flow
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.3.1. Market size and forecast, by end user
4.3. Continuous Flow
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.3.3.1. Market size and forecast, by end user
CHAPTER 5: MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT
5.1. Overview
5.1.1. Market size and forecast
5.2. Portable
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Fixed
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
CHAPTER 6: MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Home Healthcare
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
CHAPTER 7: MEDICAL OXYGEN GAS CYLINDERS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key opportunities and forecast
7.2.2. Market size and forecast, by country
7.2.3. Market size and forecast, by technology
7.2.4. Market size and forecast, by product
7.2.5. Market size and forecast, by end user
7.2.5.1. U. S.
7.2.5.1.1. U. S market size and forecast, by technology
7.2.5.1.2. U. S market size and forecast, by product
7.2.5.1.3. U. S market size and forecast, by end user
7.2.5.2. Canada
7.2.5.2.1. Canada market size and forecast, by technology
7.2.5.2.2. Canada market size and forecast, by product
7.2.5.2.3. Canada market size and forecast, by end user
7.2.5.3. Mexico
7.2.5.3.1. Mexico market size and forecast, by technology
7.2.5.3.2. Mexico market size and forecast, by product
7.2.5.3.3. Mexico market size and forecast, by end user
7.3. Europe
7.3.1. Key opportunities and forecast
7.3.2. Market size and forecast, by country
7.3.3. Market size and forecast, by technology
7.3.4. Market size and forecast, by product
7.3.5. Market size and forecast, by end user
7.3.5.1. Germany
7.3.5.1.1. Germany market size and forecast, by technology
7.3.5.1.2. Germany market size and forecast, by product
7.3.5.1.3. Germany market size and forecast, by end user
7.3.5.2. France
7.3.5.2.1. France market size and forecast, by technology
7.3.5.2.2. France market size and forecast, by product
7.3.5.2.3. France market size and forecast, by end user
7.3.5.3. UK
7.3.5.3.1. UK market size and forecast, by technology
7.3.5.3.2. UK market size and forecast, by product
7.3.5.3.3. UK market size and forecast, by end user
7.3.5.4. Italy
7.3.5.4.1. Italy market size and forecast, by technology
7.3.5.4.2. Italy market size and forecast, by product
7.3.5.4.3. Italy market size and forecast, by end user
7.3.5.5. Spain
7.3.5.5.1. Spain market size and forecast, by technology
7.3.5.5.2. Spain market size and forecast, by product
7.3.5.5.3. Spain market size and forecast, by end user
7.3.5.6. Rest of Europe
7.3.5.6.1. Rest of Europe market size and forecast, by technology
7.3.5.6.2. Rest of Europe market size and forecast, by product
7.3.5.6.3. Rest of Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key opportunities and forecast
7.4.2. Market size and forecast, by country
7.4.3. Market size and forecast, by technology
7.4.4. Market size and forecast, by product
7.4.5. Market size and forecast, by end user
7.4.5.1. Japan
7.4.5.1.1. Japan market size and forecast, by technology
7.4.5.1.2. Japan market size and forecast, by product
7.4.5.1.3. Japan market size and forecast, by end user
7.4.5.2. China
7.4.5.2.1. China market size and forecast, by technology
7.4.5.2.2. China market size and forecast, by product
7.4.5.2.3. China market size and forecast, by end user
7.4.5.3. Australia
7.4.5.3.1. Australia market size and forecast, by technology
7.4.5.3.2. Australia market size and forecast, by product
7.4.5.3.3. Australia market size and forecast, by end user
7.4.5.4. India
7.4.5.4.1. India market size and forecast, by technology
7.4.5.4.2. India market size and forecast, by product
7.4.5.4.3. India market size and forecast, by end user
7.4.5.5. Rest of Asia-Pacific
7.4.5.5.1. Rest of Asia-Pacific market size and forecast, by technology
7.4.5.5.2. Rest of Asia-Pacific market size and forecast, by product
7.4.5.5.3. Rest of Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key opportunities and forecast
7.5.2. Market size and forecast, by country
7.5.3. Market size and forecast, by technology
7.5.4. Market size and forecast, by product
7.5.5. Market size and forecast, by end user
7.5.5.1. Brazil
7.5.5.1.1. Brazil market size and forecast, by technology
7.5.5.1.2. Brazil market size and forecast, by product
7.5.5.1.3. Brazil market size and forecast, by end user
7.5.5.2. Saudi Arabia
7.5.5.2.1. Saudi Arabia market size and forecast, by technology
7.5.5.2.2. Saudi Arabia market size and forecast, by product
7.5.5.2.3. Saudi Arabia market size and forecast, by end user
7.5.5.3. South Africa
7.5.5.3.1. South Africa market size and forecast, by technology
7.5.5.3.2. South Africa market size and forecast, by product
7.5.5.3.3. South Africa market size and forecast, by end user
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Rest of LAMEA market size and forecast, by technology
7.5.5.4.2. Rest of LAMEA market size and forecast, by product
7.5.5.4.3. Rest of LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. AIRGAS, AN AIR LIQUIDE COMPANY
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. DEVILBISS HEALTHCARE
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.3. INOGEN, INC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.3.4. Business performance
8.4. INVACARE CORPORATION
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.5. KONINKLIJKE PHILIPS N. V.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. MESSE DÜSSELDORF GMBH
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Product portfolio
8.7. MESSER GROUP GMBH
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. NIDEK MEDICAL PRODUCTS, INC
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.9. ORIENTMED INTERNATIONAL FZE
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.10. RESMED INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
LIST OF TABLESLIST OF TABLES
TABLE 01. GLOBAL MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE, BY TECHNOLOGY, 2020-2030 ($MILLION)
TABLE 02. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR PULSE FLOW, BY REGION, 2020-2030($MILLION)
TABLE 03. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR PULSE FLOW, BY END USER, 2020-2030($MILLION)
TABLE 04. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR CONTINUOUS FLOW, BY REGION, 2020-2028($MILLION)
TABLE 05. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR CONTINUOUS FLOW, BY END USER, 2020-2030($MILLION)
TABLE 06. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE, BY PRODUCT, 2020-2030($MILLION)
TABLE 07. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR PORTABLE, BY REGION, 2020-2030($MILLION)
TABLE 08. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR FIXED, BY REGION, 2020-2030 ($MILLION)
TABLE 09. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE, BY END USER, 2020-2030($MILLION)
TABLE 10. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR HOSPITALS, BY REGION, 2020-2030($MILLION)
TABLE 11. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR HOME HEALTHCARE, BY REGION, 2020-2030($MILLION)
TABLE 12. MEDICAL OXYGEN GAS CYLINDERS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 13. NORTH AMERICA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 14. NORTH AMERICA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 15. NORTH AMERICA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 16. NORTH AMERICA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 17. U.S.MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 18. U.S.MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 19. U.S.MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 20. CANADA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 21. CANADA. MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 22. CANADA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 23. MEXICO MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 24. MEXICO MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 25. MEXICO MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 26. EUROPE MEDICAL OXYGEN GAS CYLINDERS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 27. EUROPE MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 28. EUROPE MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 29. EUROPE MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 30. GERMANY MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 31. GERMANY MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 32. GERMANY MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 33. FRANCE MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 34. FRANCE MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 35. FRANCE MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 36. UK MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 37. UK MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 38. UK MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 39. ITALY MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 40. ITALY MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 41. ITALY. MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 42. SPAIN MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 43. SPAIN MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 44. SPAIN MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 45. REST OF EUROPE MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 46. REST OF EUROPE MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 47. REST OF EUROPE MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 48. ASIA-PACIFIC MEDICAL OXYGEN GAS CYLINDERS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 49. ASIA-PACIFIC MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 50. ASIA-PACIFIC MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 51. ASIA-PACIFIC MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 52. JAPAN MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 53. JAPAN MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 54. JAPAN MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 55. CHINA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 56. CHINA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 57. CHINA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 58. AUSTRALIA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 59. AUSTRALIA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 60. AUSTRALIA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 61. INDIA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 62. INDIA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 63. INDIA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 64. REST OF ASIA-PACIFIC MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 65. REST OF ASIA-PACIFIC MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 66. REST OF ASIA-PACIFIC MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 67. LAMEA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 68. LAMEA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 69. LAMEA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 70. LAMEA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 71. BRAZIL MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 72. BRAZIL MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 73. BRAZIL MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 74. SAUDI ARABIA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 75. SAUDI ARABIA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 76. SAUDI ARABIA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 77. SOUTH AFRICA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 78. SOUTH AFRICA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 79. SOUTH AFRICA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 80. REST OF LAMEA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY TECHNOLOGY, 2020-2030($MILLION)
TABLE 81. REST OF LAMEA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY PRODUCT, 2020-2030($MILLION)
TABLE 82. REST OF LAMEA MEDICAL OXYGEN GAS CYLINDERS MARKET, BY END USER, 2020-2030($MILLION)
TABLE 83. AIRGAS: COMPANY SNAPSHOT
TABLE 84. AIRGAS: PRODUCT SEGMENTS
TABLE 85. AIRGAS: PRODUCT PORTFOLIO
TABLE 86. AIRGAS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 87. DEVILBISS: COMPANY SNAPSHOT
TABLE 88. DEVILBISS: OPERATING SEGMENTS
TABLE 89. DEVILBISS: PRODUCT PORTFOLIO
TABLE 90. INOGEN: COMPANY SNAPSHOT
TABLE 91. INOGEN: PRODUCT PORTFOLIO
TABLE 92. INVACARE: COMPANY SNAPSHOT
TABLE 93. INVACARE: OPERATING BUSINESS SEGMENTS
TABLE 94. INVACARE: PRODUCT PORTFOLIO
TABLE 95. PHILIPS.: COMPANY SNAPSHOT
TABLE 96. PHILIPS: OPERATING BUSINESS SEGMENTS
TABLE 97. PHILIPS: PRODUCT PORTFOLIO
TABLE 98. MESSE DÜSSELDORF: COMPANY SNAPSHOT
TABLE 99. MESSE DÜSSELDORF: PRODUCT PORTFOLIO
TABLE 100. MESSER GROUP: COMPANY SNAPSHOT
TABLE 101. MESSER GROUP: OPERATING BUSINESS SEGMENTS
TABLE 102. MESSER GROUP: PRODUCT PORTFOLIO
TABLE 103. NIDEK MEDICAL: COMPANY SNAPSHOT
TABLE 104. NIDEK MEDICAL: OPERATING SEGMENTS
TABLE 105. NIDEK MEDICAL: PRODUCT PORTFOLIO
TABLE 106. ORIENTMED: COMPANY SNAPSHOT
TABLE 107. ORIENTMED: OPERATING SEGMENTS
TABLE 108. ORIENTMED: PRODUCT PORTFOLIO
TABLE 109. RESMED: COMPANY SNAPSHOT
TABLE 110. RESMED: OPERATING SEGMENTS
TABLE 111. RESMED: PRODUCT PORTFOLIOLIST OF FIGURES
FIGURE 01. MEDICAL OXYGEN GAS CYLINDERS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. MODERATE BARGAINING POWER OF BUYERS
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. MODERATE THREAT OF SUBSTITUTION
FIGURE 07. MODERATE COMPETITIVE RIVALRY
FIGURE 08. TOP PLAYER POSITIONING, 2020
FIGURE 09. DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 10. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR PULSE FLOW, BY COUNTRY, 2020-2030 (%)
FIGURE 11. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR CONTINUOUS FLOW, BY COUNTRY, 2020-2030(%)
FIGURE 12. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR PORTABLE, BY COUNTRY, 2020-2030(%)
FIGURE 13. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR FIXED, BY COUNTRY, 2020-2030(%)
FIGURE 14. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR HOSPITAL, BY COUNTRY, 2020-2030(%)
FIGURE 15. MEDICAL OXYGEN GAS CYLINDERS MARKET REVENUE FOR HOME HEALTHCARE, BY COUNTRY, 2020-2030(%)
FIGURE 16. AIRGAS: NET SALES, 2018-2020 ($MILLION)
FIGURE 17. AIRGAS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 18. AIRGAS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 19. INOGEN: NET SALES, 2018-2020 ($MILLION)
FIGURE 20. INOGEN: REVENUE SHARE BY REGION & CATEGORY, 2020 (%)
FIGURE 21. INVACARE: NET SALES, 2018-2020 ($MILLION)
FIGURE 22. INVACARE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 23. INVACARE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 24. PHILIPS: NET SALES, 2018-2020 ($MILLION)
FIGURE 25. PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26. PHILIPS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 27. MESSER GROUP: NET SALES, 2018-2020 ($MILLION
FIGURE 28. MESSER GROUP: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29. MESSER GROUP: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 30. RESMED: NET SALES, 2018-2020 ($MILLION)
FIGURE 31. RESMED: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32. RESMED: REVENUE SHARE BY REGION, 2020(%)
Companies Mentioned
- Koninklijke Philips N.V.
- Invacare Corporation
- Nidek Medical Products Inc.
- Inogen Inc.
- Messe Düsseldorf GmbH
- ResMed
- DeVilbiss Healthcare LLC
- Airgas Inc
- Messer Group GmbH
- OrientMEd International.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 196 |
| Published | July 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 2971.4 million |
| Forecasted Market Value ( USD | $ 5337.5 million |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
